Vicor Manufacturing Head Executes Exercise-and-Sell, Realizes Roughly $1.36M in Stock Sales

General Manager of Manufacturing Operations sells and concurrently exercises options on 7,174 shares amid a strong share run

By Jordan Park VICR

Vicor Manufacturing Head Executes Exercise-and-Sell, Realizes Roughly $1.36M in Stock Sales

VICR

Michael McNamara, Vicor Corp's General Manager of Manufacturing Operations, sold 7,174 shares on March 17, 2026, for about $1.36 million while exercising an equal number of options the same day. The combined transactions reflect an exercise-and-sell approach that produced net proceeds exceeding $1 million. Market valuation analysis from InvestingPro indicates Vicor appears overvalued relative to its Fair Value.

Key Points

Michael McNamara sold 7,174 Vicor shares on March 17, 2026, for about $1.36 million at $190.07 per share.
On the same day he exercised options to acquire 7,174 shares, paying between $41.61 and $60.61 per share for a total of $330,202, reflecting an exercise-and-sell transaction that netted over $1 million.
InvestingPro's analysis flags Vicor as appearing overvalued relative to its Fair Value; the stock had gained 270% over the past year and 79% year-to-date.

Michael McNamara, who serves as General Manager of Manufacturing Operations at Vicor Corp (NASDAQ: VICR), completed a pair of linked equity transactions on March 17, 2026. On that date McNamara disposed of 7,174 shares of common stock for an aggregate amount of approximately $1.36 million, selling at $190.07 per share.

That sale price stood slightly below the stock's quoted market level at the time of the report, which was $198.11 per share. The sale followed a period of pronounced share-price appreciation for Vicor - the companyxperienced a 270% return over the prior 12 months and a 79% gain year-to-date.

Concurrently, McNamara exercised stock options to acquire 7,174 shares, paying strike prices that ranged from $41.61 to $60.61 per share. The cash value paid for those option exercises totaled $330,202. Taken together, the transactions represent a classic exercise-and-sell sequence, yielding McNamara in excess of $1 million in net proceeds after accounting for the exercise outlay and the subsequent sale.

Market context and valuation note

InvestingPro analysis included with the transaction report indicates that Vicor currently appears overvalued relative to its Fair Value. The platform also notes that detailed Pro Research Reports covering Vicor and more than 1,400 U.S. equities are available for investors seeking deeper analysis.

What happened - concise chronology

March 17, 2026 - McNamara sold 7,174 shares at $190.07 each, realizing roughly $1.36 million in gross proceeds.
Same day - McNamara exercised options to purchase 7,174 shares, paying between $41.61 and $60.61 per share, for a total exercise cost of $330,202.
The combined transactions are characterized as an exercise-and-sell strategy, producing net proceeds in excess of $1 million.

Note on available information

The filing establishes the transaction sizes, prices, and dates cited above. Beyond those items, the public record provided does not disclose further motivations or additional contextual details regarding the decision-making behind the exercise-and-sell execution.

Risks

InvestingPro analysis indicates Vicor appears overvalued relative to its Fair Value - this raises valuation risk for equity investors in the semiconductor component and manufacturing sectors.
The insider sale occurred after a substantial share-price run (270% over the past year and 79% year-to-date), a factor that may contribute to continued price variability in the market.
Public disclosures detail the mechanics and amounts of the transactions but do not provide additional context around the motivations for McNamara's exercise-and-sell, leaving an informational gap about intent.

Menu

Vicor Manufacturing Head Executes Exercise-and-Sell, Realizes Roughly $1.36M in Stock Sales

Key Points

Risks

More from Insider Trading